Compounds > phosphatidylcholines
Page last updated: 2024-09-05

phosphatidylcholines and gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate

phosphatidylcholines has been researched along with gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate in 1 studies

Compound Research Comparison

Studies
(phosphatidylcholines)		Trials
(phosphatidylcholines)		Recent Studies (post-2010)
(phosphatidylcholines)		Studies
(gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate)		Trials
(gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate)		Recent Studies (post-2010) (gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate)
32,2044435,59363831243

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Al Zaki, A; Aspinwall, CA; Cheng, Z; Hall, HK; Jones, IW; Tsourkas, A1

Other Studies

1 other study(ies) available for phosphatidylcholines and gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate

ArticleYear
Stabilized porous liposomes with encapsulated Gd-labeled dextran as a highly efficient MRI contrast agent.
    Chemical communications (Cambridge, England), 2014, Mar-07, Volume: 50, Issue:19

    Topics: Contrast Media; Dextrans; Fluorescein-5-isothiocyanate; Gadolinium; Heterocyclic Compounds; Liposomes; Magnetic Resonance Imaging; Organometallic Compounds; Phosphatidylcholines; Porosity

2014